Current Alzheimer Research


Prof. Debomoy K. Lahiri
(16607 citations)
Neuroscience Research Center
Indianapolis, IN 46202

Nobel Laureates on Editorial Board

Prof. Jean-Marie Lehn

Prof. Ferid Murad

Personal Subscription
Become EABM
Become Reviewer

Editorial: Advances in Alzheimer Therapy: Something Old, Something New, Something Borrowed, Something Blue promotion: free to download

Volume:2   Issue: 3
Pp: 275-279
Nigel H. Greig, Debomoy K. Lahiri and Ezio Giacobini
DOI: 10.2174/1567205054367865

An Overview of Phenserine Tartrate, A Novel Acetylcholinesterase Inhibitor for the Treatment of Alzheimers Disease

Volume:2   Issue: 3
Pp: 281-290
Nigel H. Greig, Kumar Sambamurti, Qian-sheng Yu, Arnold Brossi, Gosse B. Bruinsma and Debomoy K. Lahiri
DOI: 10.2174/1567205054367829

Memory Deficits Correlating with Acetylcholinesterase Splice Shift and Amyloid Burden in Doubly Transgenic Mice

Volume:2   Issue: 3
Pp: 291-300
Tina M. Rees, Amit Berson, Ella H. Sklan, Linda Younkin, Steven Younkin, Stephen Brimijoin and Hermona Soreq
DOI: 10.2174/1567205054367847

Acetylcholinesterase-Amyloid-β-peptide Interaction: Effect of Congo Red and the Role of the Wnt Pathway

Volume:2   Issue: 3
Pp: 301-306
Nibaldo C. Inestrosa, Alejandra Alvarez, Margarita C. Dinamarca, Tomas Perez-Acle and Marcela Colombres
DOI: 10.2174/1567205054367928

Cholinesterases: Roles in the Brain During Health and Disease

Volume:2   Issue: 3
Pp: 307-318
Clive G. Ballard, Nigel H. Greig, Angela L. Guillozet-Bongaarts, Albert Enz and Sultan Darvesh
DOI: 10.2174/1567205054367838

JLK Inhibitors: Isocoumarin Compounds as Putative Probes to Selectively Target the γ-Secretase Pathway

Volume:2   Issue: 3
Pp: 327-334
Checler Frederic, Alves da Costa Cristine, Ayral Erwan, Andrau David, Dumanchin Cecile, Farzan Michael, Hernandez Jean-Francois, J. Martinez, Lefranc-Jullien Solveig, Marambaud Philippe, Pasini Andrea, Petit Agnes, Phiel Christopher, Robert Philippe, St George-Hyslop Peter and Wilk Sherwin
DOI: 10.2174/1567205054367874

Pharmacological Approaches of Neurofibrillary Degeneration

Volume:2   Issue: 3
Pp: 335-341
Khalid Iqbal and Inge Grundke-Iqbal
DOI: 10.2174/1567205054367810

Atorvastatin Therapy Lowers Circulating Cholesterol but not Free Radical Activity in Advance of Identifiable Clinical Benefit in the Treatment of Mild-to-Moderate AD

Volume:2   Issue: 3
Pp: 343-353
D. Larry Sparks, Marwan N. Sabbagh, Donald J. Connor, Jean Lopez, Lenore J. Launer, Suzana Petanceska, Patrick Browne, Dawn Wassar, Sherry Johnson-Traver and Jeff Lochhead
DOI: 10.2174/1567205054367900